SCHEMBL6094641

SCHEMBL6094641

COc1cccc2[nH]cc(C3=C(Cl)C(=O)C=C(Cl)C3=O)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.44
HTR2B P41595 2/20 0.43
HTR1A P08908 1/20 0.43
HTR7 P34969 1/20 0.43
HTR5A P47898 1/20 0.43
MMP9 P14780 1/20 0.41
HTR6 P50406 1/20 0.39
HTR2C P28335 1/20 0.39
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.36
DRD2 P14416 2/20 0.36
DRD3 P35462 2/20 0.36
NR4A2 P43354 1/20 0.35
APAF1 O14727 1/20 0.35
MITF O75030 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6094532 0.84 HTR2A (0.40) HTR2ANR4A2AURKAABL1CDK4
SCHEMBL6096903 0.83 GPR84 (0.42) NR4A2AURKAABL1CDK4CCND1
SCHEMBL6096170 0.81 CYP2A6 (0.41) AURKAAURKB
SCHEMBL6097076 0.81 GPR84 (0.40) HTR2AHTR2BHTR1AHTR7HTR6
SCHEMBL6095726 0.81 ALDH1A1 (0.44) HTR2AHTR6MTNR1AMTNR1BAPAF1
SCHEMBL6099166 0.78 CDK4 (0.39) MTNR1AMTNR1BALDH1A1MAPTKDR
SCHEMBL6096141 0.76 HTR2A (0.44) HTR2AHTR2BHTR1AHTR7HTR5A
SCHEMBL6097734 0.75 PRKCB (0.54) HTTABL1PDGFRBCDK4CCND1
SCHEMBL6094431 0.73 KDR (0.50) HTR2BHTR1AHTR7HTR6HTR2C
SCHEMBL28504830 0.72 CDC25B (0.46) HTR2AHTR2BHTR1AHTR7HTR5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7057052-B2 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY (US) 2006-06-06 US disclosed
WO-2004050014-A2 SETEROCYCLIC QUINONES AS PHARMACEUTICAL AGENTS DUKE UNIVERSITY (US) 2004-06-17 WO disclosed
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents NQO1, RECQL, SDHA HTR2A 1843/4885HTR2B 3008/4885HTR1A 2061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.